Education Days
NET Presentations
Webinars
ConferencesNET EDUCATION
NET Guidelines
NET Reference Guide
CNETS One Pager
NutritionNET RESOURCES
Support Group Meetings,
CNETS Canada Fundraisers,
Patient Education Days,
Awareness Campaigns and more.
CNETS CALENDAR
NET Cancer Day,
NET Awareness Videos,
Press ReleasesNET AWARENESS

How We Help

0
Donated to NET cancer research
0
Annual visitors to online resources
0
Annual patient email and phone inquiries
0
Patient & caregiver education sessions
HELP US HELP OTHERS

NET Cancer is the FASTEST growing class of CANCER worldwide

HELP US HELP OTHERS

Neuroendocrine Tumours (NETs) Overview

  • Neuroendocrine tumours (NETs) are abnormal growth of cells (neoplasms) that arise from cells of the diffuse neuroendocrine system.
  • NETs are considered complex tumours because both tumor growth and hormonal function must be addressed.
  • NETs are most common in the lung or gastrointestinal system, but they can also originate in other parts of the body such as the thyroid, thymus, pancreas, adrenals, paraganglia, ovaries and testes.
  • NETs are classified as functional (produce hormones that cause symptoms), or non-functional (may or may not produce hormones and do not cause hormonal symptoms).
  • The cause of NETs is currently unknown.

Contact Us For Live Support

Support Lines:

416-628-3189

Toll Free: 1-844-628-6788

Latest CNETS Canada News

Patient Survey: pCODR Patient Advocacy Group Input on a Drug Review for Everolimus (Afinitor): Indication for Gastrointestinal and Lung Neuroendocrine Tumours

April 16th, 2016|0 Comments

The Pan-Canadian Oncology Drug Review (pCODR) will be considering an application for the drug Everolimus (Afinitor) indicated for Gastrointestinal and Lung Neuroendocrine (NET) Tumours.  Everolimus is a cancer medicine that interferes with the growth of […]

PRRT clinical trial at CHU de Québec

April 12th, 2016|0 Comments

We are pleased to announce that this week, we are officially launching our 177Lu-octreotate PRRT clinical trial at CHU de Québec, which is called:

Personalized Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: A Phase 2 Study

Our […]

CNETS Canada Launches New Website

April 3rd, 2016|0 Comments

Jackie’s message…coming soon

Increased Understanding Can Save Lives

March 8th, 2016|0 Comments

CNETS Canada’s President, Jackie Herman is quoted in Maclean’s Magazine Digestive Health Supplement

Donate to CNETS Canada